Die Rolle des PSMA-PET/CT bei Patienten mit metastasiertem Prostatakarzinom

Prostate-specific membrane antigen (PSMA) positron emission tomography-computed tomography (PET-CT) imaging for the localization of prostate cancer is increasingly available in Germany. The advances and limitations in different disease stages are reviewed. As the clinical relevance of oligometastati...

Full description

Saved in:
Bibliographic Details
Main Authors: Hardenberg, Jost von (Author) , Büsing, Karen-Anett (Author) , Nuhn, Philipp (Author) , Ritter, Manuel (Author)
Format: Article (Journal)
Language:German
Published: 4. Oktober 2017
In: Der Urologe
Year: 2017, Volume: 56, Issue: 11, Pages: 1410-1416
DOI:10.1007/s00120-017-0513-2
Online Access:Verlag, Volltext: http://dx.doi.org/10.1007/s00120-017-0513-2
Verlag, Volltext: https://link.springer.com/article/10.1007/s00120-017-0513-2
Get full text
Author Notes:J. von Hardenberg, K.-A. Büsing, P. Nuhn, M. Ritter

MARC

LEADER 00000caa a2200000 c 4500
001 157791208X
003 DE-627
005 20230426230739.0
007 cr uuu---uuuuu
008 180725s2017 xx |||||o 00| ||ger c
024 7 |a 10.1007/s00120-017-0513-2  |2 doi 
035 |a (DE-627)157791208X 
035 |a (DE-576)50791208X 
035 |a (DE-599)BSZ50791208X 
035 |a (OCoLC)1341014402 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a ger 
084 |a 33  |2 sdnb 
100 1 |a Hardenberg, Jost von  |d 1982-  |e VerfasserIn  |0 (DE-588)1020494328  |0 (DE-627)688149278  |0 (DE-576)360578241  |4 aut 
245 1 4 |a Die Rolle des PSMA-PET/CT bei Patienten mit metastasiertem Prostatakarzinom  |c J. von Hardenberg, K.-A. Büsing, P. Nuhn, M. Ritter 
264 1 |c 4. Oktober 2017 
300 |b Illustrationen 
300 |a 7 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 25.07.2018 
520 |a Prostate-specific membrane antigen (PSMA) positron emission tomography-computed tomography (PET-CT) imaging for the localization of prostate cancer is increasingly available in Germany. The advances and limitations in different disease stages are reviewed. As the clinical relevance of oligometastatic disease in primary cancer detected by PSMA PET-CT imaging is not yet completely understood, it should only be used in clinical trials. In recurrent prostate cancer after therapy with curative intent, PSMA PET-CT shows encouraging potential for the planning of salvage therapy. In metastatic castration-resistant prostate cancer evidence for its use is not available. 
650 4 |a Castration-resistant prostate cancer (CRPC) 
650 4 |a Kastrationsresistentes Prostatakarzinom (CRPC) 
650 4 |a Oligometastases 
650 4 |a Oligometastasierung 
650 4 |a Primärdiagnostik 
650 4 |a Primary diagnostic 
650 4 |a Prostatectomy 
650 4 |a Prostatektomie 
650 4 |a radical 
650 4 |a radikale 
650 4 |a Recurrence 
650 4 |a Rezidivdiagnostik 
700 1 |a Büsing, Karen-Anett  |d 1970-  |e VerfasserIn  |0 (DE-588)123814634  |0 (DE-627)706436032  |0 (DE-576)293891222  |4 aut 
700 1 |a Nuhn, Philipp  |d 1981-  |e VerfasserIn  |0 (DE-588)136112951  |0 (DE-627)694090808  |0 (DE-576)30083909X  |4 aut 
700 1 |a Ritter, Manuel  |d 1979-  |e VerfasserIn  |0 (DE-588)1030329915  |0 (DE-627)73508436X  |0 (DE-576)378128256  |4 aut 
773 0 8 |i Enthalten in  |t Der Urologe  |d [Berlin : Springer Medizin, 2005  |g 56(2017), 11, Seite 1410-1416  |h Online-Ressource  |w (DE-627)101704192X  |w (DE-600)2925337-8  |w (DE-576)501620842  |7 nnas  |a Die Rolle des PSMA-PET/CT bei Patienten mit metastasiertem Prostatakarzinom 
773 1 8 |g volume:56  |g year:2017  |g number:11  |g pages:1410-1416  |g extent:7  |a Die Rolle des PSMA-PET/CT bei Patienten mit metastasiertem Prostatakarzinom 
856 4 0 |u http://dx.doi.org/10.1007/s00120-017-0513-2  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u https://link.springer.com/article/10.1007/s00120-017-0513-2  |x Verlag  |3 Volltext 
951 |a AR 
992 |a 20180725 
993 |a Article 
994 |a 2017 
998 |g 1030329915  |a Ritter, Manuel  |m 1030329915:Ritter, Manuel  |d 60000  |d 63100  |e 60000PR1030329915  |e 63100PR1030329915  |k 0/60000/  |k 1/60000/63100/  |p 4  |y j 
998 |g 136112951  |a Nuhn, Philipp  |m 136112951:Nuhn, Philipp  |d 60000  |d 63100  |e 60000PN136112951  |e 63100PN136112951  |k 0/60000/  |k 1/60000/63100/  |p 3 
998 |g 123814634  |a Büsing, Karen-Anett  |m 123814634:Büsing, Karen-Anett  |d 60000  |d 62900  |e 60000PB123814634  |e 62900PB123814634  |k 0/60000/  |k 1/60000/62900/  |p 2 
998 |g 1020494328  |a Hardenberg, Jost von  |m 1020494328:Hardenberg, Jost von  |d 60000  |d 63100  |e 60000PH1020494328  |e 63100PH1020494328  |k 0/60000/  |k 1/60000/63100/  |p 1  |x j 
999 |a KXP-PPN157791208X  |e 3019470188 
BIB |a Y 
SER |a journal 
JSO |a {"name":{"displayForm":["J. von Hardenberg, K.-A. Büsing, P. Nuhn, M. Ritter"]},"recId":"157791208X","id":{"doi":["10.1007/s00120-017-0513-2"],"eki":["157791208X"]},"title":[{"title":"Die Rolle des PSMA-PET/CT bei Patienten mit metastasiertem Prostatakarzinom","title_sort":"Rolle des PSMA-PET/CT bei Patienten mit metastasiertem Prostatakarzinom"}],"person":[{"role":"aut","family":"Hardenberg","roleDisplay":"VerfasserIn","given":"Jost von","display":"Hardenberg, Jost von"},{"display":"Büsing, Karen-Anett","roleDisplay":"VerfasserIn","given":"Karen-Anett","family":"Büsing","role":"aut"},{"role":"aut","display":"Nuhn, Philipp","roleDisplay":"VerfasserIn","given":"Philipp","family":"Nuhn"},{"roleDisplay":"VerfasserIn","display":"Ritter, Manuel","given":"Manuel","family":"Ritter","role":"aut"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"origin":[{"dateIssuedKey":"2017","dateIssuedDisp":"4. Oktober 2017"}],"language":["ger"],"relHost":[{"corporate":[{"role":"isb","roleDisplay":"Herausgebendes Organ","display":"Deutsche Gesellschaft für Urologie"}],"origin":[{"dateIssuedDisp":"[2005-2022]","publisher":"Springer Medizin","publisherPlace":"[Berlin ; Heidelberg ; New York]"}],"physDesc":[{"extent":"Online-Ressource"}],"note":["Gesehen am 05.07.2022"],"language":["ger"],"disp":"Die Rolle des PSMA-PET/CT bei Patienten mit metastasiertem ProstatakarzinomDer Urologe","recId":"101704192X","id":{"zdb":["2925337-8"],"eki":["101704192X"]},"name":{"displayForm":["Deutsche Gesellschaft für Urologie"]},"pubHistory":["Volume 44, issue 7 (July 2005)-volume 61, issue 5 (May 2022)"],"part":{"issue":"11","pages":"1410-1416","year":"2017","extent":"7","text":"56(2017), 11, Seite 1410-1416","volume":"56"},"type":{"bibl":"periodical","media":"Online-Ressource"},"title":[{"title":"Der Urologe","title_sort":"Urologe"}]}],"physDesc":[{"extent":"7 S.","noteIll":"Illustrationen"}],"note":["Gesehen am 25.07.2018"]} 
SRT |a HARDENBERGROLLEDESPS4201